ArticleActa pharmacologica Sinica2025
METTL14-mediated m
Abstract read
In one paragraph
Article in Acta pharmacologica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- mBiomolecules · 2026Review
- Nicotine promotes cardiac fibrosis by regulating miR-125b-5p maturation via HNRNPA2B1-mediated METTL14-dependent m⁶A methylation: therapeutic reversal by cinacalcet HCl.Journal of translational medicine · 2026Article
- The silent dialogue between cells: regulatory roles of non-coding RNAs in cardiovascular disease.Frontiers in cell and developmental biology · 2026Review
- Pyroptosis Regulated by N6-Methyladenosine Modification: Implications for Pyroptosis-Related Disease Therapy.Journal of innate immunity · 2026Review
- Acute Myocardial Infarction: Molecular Pathogenesis, Diagnosis, and Clinical Management.MedComm · 2025Review
- Alkbh5 promotes Ythdf1 expression through demethylation thereby facilitating Fth1 translation to inhibit ferroptosis of myocardial infarction.BMC cardiovascular disorders · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Hang Yu *Department of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Qing-Sui Li *Department of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Jun-Nan Guo *Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, 150040, China.
Zhen ZhangDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Xian-Zhi LangDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Yi-Ning LiuDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Long QinDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Xu SuDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Qing-Wei ZhangDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Ya-Dong XueDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Li-Ling GongDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Ning XuDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Ming LiDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Wen-Shuang ZhaoDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Xing-Miao ZhaoDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Wan-Yu ZhangDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Yi-Jing YaoDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Xi-Ming ChenDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Zhen ZhangDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Wei LiDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Han-Xiang WangDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Ben-Zhi CaiDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China. caibz@ems.hrbmu.edu.cn.
Jia-Min LiDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China. lijiamin@hrbmu.edu.cn.
Ning WangDepartment of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD)), College of Pharmacy, Harbin Medical University, Harbin, 150081, China. wangning@ems.hrbmu.edu.cn.
Funding
No grant is acknowledged in the PubMed record.
Abstract
N
Indexed as
AdenosineMethyltransferasesMicroRNAsMyocardial InfarctionMyocytes, CardiacPyroptosisAnimalsMaleMethylationMiceMice, Inbred C57BLAdenosineMethyltransferasesMettl14 protein, mouseMicroRNAsMir5099, mouseN-methyladenosinecardiomyocyte pyroptosisELF1m6A modificationMETTL14miRNA-5099-3pmyocardial infarction
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.